MYCLAD Trademark
Serial Number: 79393880 • Registration: 7629053
MYCLAD is a trademark filed by
Merck KGaA
on March 19, 2024. The trademark is classified under Class 42 (Computer & Scientific).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
William C. Wright Epstein Drangel LLP
60 East 42nd Street, Suite 1250
New York, NY 10165
United States
Trademark Details
Filing Date
March 19, 2024
Registration Date
December 31, 2024
Published for Opposition
November 12, 2024
Goods & Services
Medical research, Clinical research in the field of neurology and immunology; Scientific research
Filing History
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 17, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 17, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 1, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 1, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 31, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 31, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 13, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 18, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 30, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 3, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 2, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 2, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 18, 2024 REPR
